Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386

Documenti analoghi

• Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells
  di: Sugano, Hiroshi, et al.
  Pubblicazione: (2018)
• Glycogen synthase kinase‐3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells
  di: Haruki, Koichiro, et al.
  Pubblicazione: (2017)
• Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
  di: Tadashi Uwagawa, et al.
  Pubblicazione: (2022-01-01)
• Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
  di: Tadashi Uwagawa, et al.
  Pubblicazione: (2022-01-01)
• Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo
  di: Saito, Nobuhiro, et al.
  Pubblicazione: (2018)